Kezar Life Sciences to Participate in Three Upcoming Investor Conferences

Author's Avatar
Sep 01, 2022

Kezar+Life+Sciences%2C+Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Christopher Kirk, PhD, Co-founder, President and Chief Scientific Officer, will participate in three upcoming investor conferences in September.